PCSA · Company research
Processa Pharmaceuticals, Inc. Common (PCSA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Processa Pharmaceuticals (PCSA) Stock Forum and Discussion - Moomoo | Processa Pharmaceuticals (PCSA) Stock Forum and Discussion Moomoo | View source ↗ | Moomoo | Oct 16, 2026 | neutral | 0 | 0.6 |
| Processa (PCSA) Climbs +12.59% — Resistance at $1.60 in Focus 2026-10-12 - MACD Signal Stocks - https://www.dars.gov.et/ | Processa (PCSA) Climbs +12.59% — Resistance at $1.60 in Focus 2026-10-12 - MACD Signal Stocks https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 12, 2026 | neutral | 0 | 0.6 |
| Processa (PCSA) Climbs +12.59% — Resistance at $1.60 in Focus 2026-10-12 - Growth ETF - https://www.siam.in/ | Processa (PCSA) Climbs +12.59% — Resistance at $1.60 in Focus 2026-10-12 - Growth ETF https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 12, 2026 | neutral | 0 | 0.6 |
| PCSA Shareholders Plan to Sell 306.57 Million Shares; Company Not Participating - GuruFocus | PCSA Shareholders Plan to Sell 306.57 Million Shares; Company Not Participating GuruFocus | View source ↗ | GuruFocus | Oct 9, 2026 | neutral | 0 | 0.6 |
| Selling stockholders would receive resale proceeds, with none going to Processa (Nasdaq: PCSA). - Stock Titan | Selling stockholders would receive resale proceeds, with none going to Processa (Nasdaq: PCSA). Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| $PCSA stock is down 14% today. Here's what we see in our data. - Quiver Quantitative | $PCSA stock is down 14% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 9, 2026 | neutral | 0 | 0.6 |
| PCSA Forecast — Price Target — Prediction for 2027 - TradingView | PCSA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Oct 1, 2026 | neutral | 0 | 0.6 |
| Mailbag: Pac-12 expansion options, PCSA's future, NCAA eligibility woes - The Mercury News | Mailbag: Pac-12 expansion options, PCSA's future, NCAA eligibility woes The Mercury News | View source ↗ | The Mercury News | Aug 28, 2026 | neutral | 0 | 0.6 |
| PCSA Stock Jumps As Traders Pile Into Biotech Micro-Cap - StocksToTrade | PCSA Stock Jumps As Traders Pile Into Biotech Micro-Cap StocksToTrade | View source ↗ | StocksToTrade | Jul 29, 2026 | neutral | 0 | 0.6 |
| PCSA Stock Jumps As Traders Zero In On Volatile Runway - www.timothysykes.com | PCSA Stock Jumps As Traders Zero In On Volatile Runway www.timothysykes.com | View source ↗ | www.timothysykes.com | Jul 29, 2026 | neutral | 0 | 0.6 |
| Processa adds BTK therapy programs for food allergy and multiple sclerosis - Stock Titan | Processa adds BTK therapy programs for food allergy and multiple sclerosis Stock Titan | View source ↗ | Stock Titan | Jul 29, 2026 | neutral | 0 | 0.6 |
| $PCSA stock is down 34% today. Here's what we see in our data. - Quiver Quantitative | $PCSA stock is down 34% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 29, 2026 | neutral | 0 | 0.6 |
| PCSA Stock Jumps As Traders Zero In On Volatile Run - StocksToTrade | PCSA Stock Jumps As Traders Zero In On Volatile Run StocksToTrade | View source ↗ | StocksToTrade | Jul 29, 2026 | neutral | 0 | 0.6 |
| PCSA: Stock-for-stock acquisition and $200M PIPE create a BTK-focused biotech with runway into 2029 - TradingView | PCSA: Stock-for-stock acquisition and $200M PIPE create a BTK-focused biotech with runway into 2029 TradingView | View source ↗ | TradingView | Jul 29, 2026 | neutral | 0 | 0.6 |
| Processa Pharmaceuticals CFO Russell Skibsted buys $5,891 in stock - Investing.com | Processa Pharmaceuticals CFO Russell Skibsted buys $5,891 in stock Investing.com | View source ↗ | Investing.com | Jun 16, 2026 | neutral | 0 | 0.6 |
| PCSA Stock Rallies 10% After Hours— Here’s Why - Stocktwits | PCSA Stock Rallies 10% After Hours— Here’s Why Stocktwits | View source ↗ | Stocktwits | Apr 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.